CONDITIONS WE TREAT
Heavy metal accumulation and impaired detoxification pathways create a persistent biological burden that drives neurological, immune, and metabolic dysfunction. SynergyO3 investigates your toxic burden and designs physician-supervised protocols to support cellular detoxification and heavy metal clearance.
CLINICAL PRESENTATION
Heavy metal toxicity and impaired detoxification present with a broad range of symptoms that overlap with many other chronic conditions. Careful evaluation including comprehensive toxic metal testing is essential for accurate diagnosis. Individual results vary.
Sources of heavy metal exposure include dental amalgam fillings (mercury), contaminated water (lead, arsenic), occupational exposures (industrial chemicals, welding), certain fish consumption (methylmercury), and legacy environmental contamination. Symptoms often develop gradually over years of cumulative exposure.
Testing may include urine toxic metal panels (provoked and unprovoked), whole blood metals, red blood cell minerals, hair element analysis, and specific markers such as delta-aminolevulinic acid (lead), urinary mercury, and arsenic speciation. Liver function, glutathione levels, and methylation pathway markers are also assessed.
COMMONLY OVERLAPPING CONDITIONS
CLINICAL EDUCATION
Heavy metals including mercury, lead, arsenic, cadmium, and aluminum disrupt biological function through multiple mechanisms: displacing essential mineral cofactors from enzyme active sites, generating reactive oxygen species, impairing mitochondrial respiration, and disrupting the methylation pathways critical for detoxification itself.
Heavy metals bind with high affinity to sulfhydryl groups on enzymes, displacing the zinc, magnesium, and iron cofactors essential for proper function. Mercury in particular inactivates over 200 enzyme systems, including those required for antioxidant defense and detoxification.
Heavy metals accumulate in mitochondria, damaging the electron transport chain, impairing ATP synthesis, and generating excessive reactive oxygen species. This mitochondrial toxicity is a primary driver of the fatigue, cognitive dysfunction, and metabolic impairment seen in heavy metal burden.
Mercury and arsenic deplete glutathione and impair the methylation cycle (folate/methionine), the body's primary detoxification pathway. When methylation is disrupted, the body's ability to neutralize and eliminate toxic metals is further compromised — creating a self-perpetuating toxic burden.
KEY STATISTICS
Comprehensive intake, targeted labs, and biomarker assessment to map biological drivers.
Physician-designed sequenced protocol combining EBOO, HOCATT, and IV nutrients.
Follow-up labs, functional benchmarks, and protocol refinement based on response.
ROOT CAUSE INVESTIGATION
Dr. Volpp evaluates each patient's complete picture — identifying which biological mechanisms are most active — before any protocol is designed. Individual results vary.
Glutathione is the primary carrier for heavy metal conjugation and elimination. Heavy metal exposure depletes glutathione reserves while simultaneously impairing its synthesis — creating a toxic accumulation cycle that requires targeted nutritional repletion to reverse.
Heavy metals catalyze the Fenton reaction, generating hydroxyl radicals — among the most reactive and damaging free radicals. This oxidative stress damages cellular membranes, DNA, and mitochondria while activating inflammatory pathways.
Mercury and lead are potent endocrine disruptors, interfering with thyroid hormone synthesis and conversion, displacing zinc needed for testosterone and growth hormone production, and disrupting the HPA axis stress response.
TREATMENT APPROACH
All protocols are physician-designed and supervised by Dr. Heather Volpp, MD. Therapies are selected based on each patient's evaluation. Results may vary.
EBOO ozone therapy may support heavy metal detoxification by upregulating glutathione and antioxidant enzyme systems critical for metal conjugation and elimination, while reducing the oxidative burden generated by metal catalysis.
The HOCATT's far-infrared and ozone steam combination supports heavy metal mobilization through perspiration and lymphatic drainage, while supporting the antioxidant systems needed to safely process released metals.
YOUR PATH FORWARD
Every patient begins with a comprehensive physician evaluation. No protocol begins before Dr. Volpp has reviewed your complete clinical picture.
A comprehensive intake with Dr. Volpp reviewing your symptom timeline, prior lab work, medications, and functional status. Targeted lab panels are ordered to identify active biological drivers.
Based on your evaluation findings, Dr. Volpp designs a sequenced treatment protocol — typically combining EBOO sessions, HOCATT therapy, and IV nutrient support at clinically appropriate intervals.
Functional benchmarks and symptom tracking guide protocol adjustments. Follow-up labs assess inflammatory markers and key biomarkers. Treatment frequency is adjusted as you progress toward your goals.
COMMON QUESTIONS
TAKE THE NEXT STEP
Begin with a comprehensive consultation with Dr. Heather Volpp, MD — Board-Certified Internal Medicine. Your evaluation will review your full clinical picture and identify which biological mechanisms may be driving your symptoms.
Book Your Appointment →Physician-Supervised · SynergyO3 Medical · Encinitas, CA · (760) 450-4602
Individual results vary. Consult with Dr. Volpp during your evaluation.
